Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K183640
    Date Cleared
    2019-02-22

    (58 days)

    Product Code
    Regulation Number
    876.1500
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    Cellvizio 100 Series Confocal laser Imaging systems and their Confocal Miniprobes

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    Cellvizio® 100 Series Systems with Confocal Miniprobes™ are confocal laser systems with fiber optic probes that are intended to allow imaging of the internal microstructure of tissues, including, but not limited to, the identification of cells and their organization or architecture.

    The AQ-Flex™ 19 Confocal Miniprobe™ is intended to allow imaging of anatomical tracts, i.e., gastrointestinal and respiratory tracts, accessed by an endoscope, or endoscopic accessories (e.g. aspiration needles used during procedures including EUS-FNA, EBUS-TBNA and TBNA needles).

    Device Description

    AQ-Flex™ 19 Confocal Miniprobes™ is used with Cellvizio® 100 Series system to provide imaging of anatomical tracts, i.e., gastrointestinal and respiratory tracts, accessed by an endoscope, or endoscopic accessories. It is designed to be used during transbronchial needle aspiration (TBNA), endoscopic ultrasound transbronchial needle aspiration (EBUS-TBNA) and endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) procedures.

    There are no changes in design, materials, or function between the subject AQ-Flex™ 19 device and the cleared AQ-Flex™ 19 Confocal Miniprobe™ (K123676, K150831, and K172844), except for the length of the AQ-Flex 19 which has been reduced from 4 to 3 meters (AQ-Flex™ 19 Confocal Miniprobe™ has previously been cleared with a length of 4 meters).

    A locking accessory already available in the package of the predicate device is used as an aid to secure placement inside the needle used during EUS-FNA procedures and can also be used during TBNA, and EBUS-TBNA procedures.

    AI/ML Overview

    Here's an analysis of the provided text regarding the acceptance criteria and study for the Cellvizio® 100 Series Confocal laser imaging systems and their Confocal Miniprobe™ AQ-Flex™ 19:

    1. Table of Acceptance Criteria and Reported Device Performance

    Test PerformedAcceptance CriteriaReported Device Performance
    Biocompatibility (Cytotoxicity, Sensitization, Irritation or Intracutaneous reactivity & Systemic toxicity)All requirements metPass
    Resistance to reprocessing methods: mechanical resistance, tensile strength assessment, functional testing, image quality etc.All requirements metPass
    Efficacy of reprocessing methodsAll requirements metPass
    Laser safetyAll requirements metPass
    Imaging qualityAll requirements metPass
    Compatibility of the AQ-Flex™ 19 Confocal Miniprobe™ with endoscopic accessories used during EUS-FNA procedures.All requirements metPass
    Compatibility of the AQ-Flex™ 19 Confocal Miniprobe™ with endoscopic accessories used during (EBUS)-TBNA procedures: Mechanical tests to verify no creation of sharp edges on distal head.Verification of smooth distal surface and absence of spikes and edges on distal tip according to ISO 8600-1 standardPass (25/25)
    Compatibility of the AQ-Flex™ 19 Confocal Miniprobe™ with endoscopic accessories used during (EBUS)-TBNA procedures: Confocal Miniprobe™ strength test by insertion/extraction and bending in (EBUS)-TBNA needles.Verification of mechanical resistance of the probe after extraction of AQ-Flex™ 19 from needle in EUS-TBNA and TBNA retroflex positionPass (25/25)
    Protrusion test of the of the AQ-Flex™ 19 Confocal Miniprobe™ length when used with (This row is incomplete in the provided text, but the intention is clear from the acceptance criteria and result for securing position.)Securing position of AQ-Flex™ 19 distal tip with (The specific conditions for securing are not fully detailed in the provided text, but the general concept is present.)Pass (5/5)

    2. Sample Sizes Used for the Test Set and Data Provenance

    The document primarily focuses on bench testing and compatibility assessments, not clinical performance studies with human data in the test set.

    • Mechanical tests for sharp edges: 25 samples ("Pass (25/25)")
    • Mechanical strength test (insertion/extraction and bending): 25 samples ("Pass (25/25)")
    • Protrusion test: 5 samples ("Pass (5/5)")

    The provenance of this data is not explicitly stated as country of origin, retrospective, or prospective. Given that these are primarily compatibility and mechanical tests, they are likely prospective bench tests conducted by the manufacturer.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications

    The document does not mention human experts being used to establish ground truth for the "test set" in the context of clinical performance. The "ground truth" for the mechanical and compatibility tests would primarily be adherence to engineering specifications and international standards (like ISO 8600-1), which are verified by testers, not expert clinicians establishing a diagnostic truth.

    4. Adjudication Method for the Test Set

    Not applicable as the reported tests are primarily objective mechanical and compatibility tests against predefined criteria and standards, not subjective assessments requiring adjudication.

    5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    There is no mention of an MRMC comparative effectiveness study in this document. The device is a confocal laser imaging system for visualizing tissue microstructure, and the submission is for an expanded indication of use for an existing component (AQ-Flex™ 19 Confocal Miniprobe™) in specific endoscopic procedures. There is no AI component or human-in-the-loop performance evaluation described.

    6. If a Standalone (i.e. algorithm only without human-in-the-loop performance) was done

    Not applicable. This device is an imaging tool that provides visual information to a human operator, not an AI algorithm performing a diagnostic task independently.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.)

    The "ground truth" for the tests reported is primarily:

    • Adherence to engineering specifications and standards (e.g., ISO 8600-1 for smooth distal surface, absence of spikes/edges).
    • Verification of mechanical integrity and functionality after stress tests.
    • Compliance with safety standards (e.g., laser safety).
    • Internal validation of performance characteristics (e.g., image quality, resistance to reprocessing).

    There is no mention of clinical ground truth such as pathology or outcomes data in this submission for the expanded indication.

    8. The Sample Size for the Training Set

    Not applicable. This document describes the testing and validation for a hardware device and its accessories, not the development or training of an algorithm or AI system.

    9. How the Ground Truth for the Training Set was Established

    Not applicable, as there is no training set for an algorithm described in this document.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1